Try our Advanced Search for more refined results

February 27, 2013

AbbVie Inc. et al v. The Kennedy Trust Rheumatology Research

Track this case

Case Number:

1:13-cv-01358

Court:

New York Southern

Nature of Suit:

Patent

Judge:

Paul A. Crotty

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. July 09, 2014

    AbbVie Gets More Humira Patent Claims Invalidated

    AbbVie Inc. on Wednesday won another ruling in New York federal court declaring invalid patent claims for the anti-inflammatory drug Humira held by the Kennedy Institute of Rheumatology Trust, notching a second victory for the drugmaker, which paid $100 million-plus in related licensing fees.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!